QTNTQ — Quotient Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.16m
- $252.30m
- $38.51m
Annual cashflow statement for Quotient, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2018 March 31st | 2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -82.3 | -105 | -103 | -108 | -125 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 8.74 | 11.8 | 12.6 | 18.1 | 0.079 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -4.58 | 5.11 | -3.08 | 2.21 | -2.37 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -68.4 | -75.7 | -80.6 | -77.6 | -119 |
| Capital Expenditures | -21.6 | -4.79 | -4.6 | -4.24 | -2.85 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 24.9 | -84.3 | -25.6 | 47.7 | 46.9 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 3.34 | -89.1 | -30.2 | 43.4 | 44.1 |
| Financing Cash Flow Items | — | -5.12 | -0.874 | — | -3.81 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 83.3 | 145 | 115 | 80.2 | 87.6 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 15.4 | -13.6 | 1.34 | 41.8 | 19.1 |